3 COVID-19 vaccine candidates under active consideration of DCGI: Health Ministry
New Delhi: Three COVID-19 vaccines candidates are under active consideration of India’s drug regulator (DCGI), the Union Health Ministry said ...
Read moreNew Delhi: Three COVID-19 vaccines candidates are under active consideration of India’s drug regulator (DCGI), the Union Health Ministry said ...
Read moreNew Delhi: After Pfizer and Serum Institute, Hyderabad-based pharmaceutical firm Bharat Biotech applied Monday to the central drug regulator seeking ...
Read moreBengaluru: The Phase-III clinical trial of Covid-19 vaccine (Covaxin) being developed by Bharat Biotech would begin at the privately-run Vydehi ...
Read moreNew Delhi: There has been a massive surge in cyber attacks against the India vaccine makers and hospitals in the ...
Read moreNew Delhi: The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS here Thursday. ...
Read moreHyderabad: Even as India's first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech Monday ...
Read moreBhubaneswar: Keeping in mind the huge demand for Covid-19 vaccine as soon as it gets the necessary approval, the state ...
Read moreNew Delhi: An Indian government-backed COVID-19 vaccine could be launched as early as February. If that COVID-19 vaccine is launched ...
Read moreNew Delhi: Bharat Biotech is planning to launch its vaccine for COVID-19 in the second quarter next year if it gets ...
Read moreBhubaneswar: The third phase of the human of the indigenous COVID-19 vaccine COVAXIN, will commence at a private hospital here ...
Read more